DAVID M. TANEN

Corporate Board Profile

Tech Score: 0/100

CAPRICOR THERAPEUTICS, INC.

Filing Date	Source Excerpt
2008-04-18	Mr. Tanen received his B.A. from The George Washington University and his J.D. from Fordham University School of Law.

TG THERAPEUTICS, INC.

Filing Date	Source Excerpt
2003-01-29	David M. Tanen, 31, has served as a member of our board of directors since January 28, 2002.
2004-07-28	David M. Tanen has been a director of the Company since January 2002. Since 1996, Mr. Tanen has served as an associate director of Paramount Capital, where he has been involved in the founding of a number of biotechnology start-up companies. Since February 2003, Mr. Tanen has also served as a director of Chiral Quest, Inc. (OTC: CQST) and he also serves as an officer or director of several other privately held development-stage biotechnology companies. Mr. Tanen holds a law degree from Fordham University School of Law. For fiscal 2003, the Audit Committee of the Board of Directors consisted of Joshua Kazam, David Tanen and Michael Weiser. None of these members meet the definition of an audit committee financial expert, as that term is defined by SEC regulations. Further, none of these members are independent, as defined by applicable regulation. The Audit Committee met 4 times in fiscal 2003. The Board created a Nominating Committee, comprised of Messrs. Herskowitz, Hoenlein, Steinhart and Tanen.

Filing Date

Source Excerpt

2003-01-29

David M. Tanen, 31, has served as a member of our board of directors since January 28, 2002.

2004-07-28

David M. Tanen has been a director of the Company since January 2002. Since 1996, Mr. Tanen has served as an associate director of Paramount Capital, where he has been involved in the founding of a number of biotechnology start-up companies. Since February 2003, Mr. Tanen has also served as a director of Chiral Quest, Inc. (OTC: CQST) and he also serves as an officer or director of several other privately held development-stage biotechnology companies. Mr. Tanen holds a law degree from Fordham University School of Law. For fiscal 2003, the Audit Committee of the Board of Directors consisted of Joshua Kazam, David Tanen and Michael Weiser. None of these members meet the definition of an audit committee financial expert, as that term is defined by SEC regulations. Further, none of these members are independent, as defined by applicable regulation. The Audit Committee met 4 times in fiscal 2003. The Board created a Nominating Committee, comprised of Messrs. Herskowitz, Hoenlein, Steinhart and Tanen.

Data sourced from SEC filings. Last updated: 2026-02-03